Indian Pharmaceuticals Say Antibiotic API Prices Could Increase By Half
This article was originally published in PharmAsia News
Executive Summary
Indian drug makers say the active pharmaceutical ingredients for antibiotics could cost as much as 50 percent more as a result of a government anti-dumping response